Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
48
Participants
Timeline
Start Date
December 31, 2004
Primary Completion Date
March 31, 2005
Study Completion Date
March 31, 2005
Conditions
Cardiovascular Disease
Interventions
DRUG
INS50589 Intravenous Infusion
Trial Locations (1)
66219
Quintiles Phase I Services, Lenexa
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00099450 - Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers | Biotech Hunter | Biotech Hunter